Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Anika Therapeutics, Inc. ANIK
$25.23
-$0.08 (-0.32%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
374300514.00000000
-
week52high
32.51
-
week52low
20.12
-
Revenue
156236000
-
P/E TTM
-25
-
Beta
0.83494800
-
EPS
-1.03000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 20:00
Описание компании
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Stephens & Co. | Equal-Weight | Overweight | 09 мар 2022 г. |
| Stephens & Co. | Overweight | 16 ноя 2021 г. | |
| UBS | Neutral | 16 июл 2021 г. | |
| Barrington Research | Outperform | Market Perform | 16 дек 2020 г. |
| Sidoti & Co. | Buy | Neutral | 22 янв 2020 г. |
| Barrington Research | Outperform | Market Perform | 09 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Levitz Michael L | D | 3859 | 3859 | 10 авг 2022 г. |
| Levitz Michael L | A | 20423 | 3859 | 10 авг 2022 г. |
| Thompson Jeffery S | A | 25075 | 7954 | 08 июн 2022 г. |
| CONLEY SHERYL L | A | 16133 | 7954 | 08 июн 2022 г. |
| HENNEMAN JOHN B III | A | 23436 | 7954 | 08 июн 2022 г. |
| Larsen Glenn R. | A | 23823 | 7954 | 08 июн 2022 г. |
| Richard Stephen | A | 21436 | 7954 | 08 июн 2022 г. |
| VOGT SUSAN L N | A | 23778 | 7954 | 08 июн 2022 г. |
| Colleran David | A | 9867 | 1500 | 11 мая 2022 г. |
| Blanchard Cheryl R | D | 24575 | 24576 | 26 апр 2022 г. |
Новостная лента
Anika Therapeutics (ANIK) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
09 мая 2023 г. в 20:37
Anika Therapeutics (ANIK) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.20 per share a year ago.
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
GlobeNewsWire
19 апр 2023 г. в 08:30
BEDFORD, Mass., April 19, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2023 financial results after the close of the market on Tuesday, May 9, 2023 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.
Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
06 мар 2023 г. в 18:49
Anika (ANIK) delivered earnings and revenue surprises of -54.55% and 3.41%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Anika Therapeutics (ANIK) Stock Outpacing Its Medical Peers This Year?
Zacks Investment Research
17 янв 2023 г. в 11:17
Here is how Anika Therapeutics (ANIK) and Achilles Therapeutics PLC Sponsored ADR (ACHL) have performed compared to their sector so far this year.
7 Stocks to Buy Before the Market Starts to Soar in 2023
InvestorPlace
10 ноя 2022 г. в 13:24
With Americans being an optimistic bunch, the general assumption that the equities sector will rise following the ugly year in 2022 fundamentally bolsters several stocks to buy. However, it's important to be selective.